Cross Country Healthcare Stock Forecast for 2023 - 2025 - 2030
Updated on 05/12/2024
Cross Country Healthcare Stock Forecast and Price Target
Cross Country Healthcare's stock is projected to advance by 23.91% from the previous closing price if it reaches the average target of $18.50 by the year's end, as six reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $21.00 and a low-end estimate of $16.00. If you are not interested in CCRN stock, you may be interested in its competitors.
23.91% Upside
Cross Country Healthcare Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Cross Country Healthcare's Price has fallen from $11.76 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $40.13, which would mean an increase of 100.00%. Over the next seven years, experts predict that Cross Country Healthcare's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
RHI Stock Forecast | Robert Half | Hold |
10
|
$70.76 | Buy/Sell | $72.50 | -1.07% |
TEP Stock Forecast | Teleperformance | Outperform |
18
|
102.60€ | Buy/Sell | 193.07€ | 46.20% |
CBZ Stock Forecast | CBIZ | Outperform |
16
|
$77.00 | Buy/Sell | $60.00 | 1.30% |
MAN Stock Forecast | ManpowerGroup | Hold |
18
|
$76.70 | Buy/Sell | $74.83 | 1.69% |
KFY Stock Forecast | Korn Ferry | Outperform |
18
|
$64.52 | Buy/Sell | $81.50 | 13.14% |
Cross Country Healthcare Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Cross Country Healthcare's Revenue has grown by 141.47%, rising from $836.42M to $2.02B. According to 7 analysts, Cross Country Healthcare's Revenue will fall by 19.21% in the next year, reaching $1.63B. Professionals believe that By 2030, Cross Country Healthcare's Revenue will fall to $1.87B – a 7.62% decrease from its current value.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
KELY.A Stock Forecast | Kelly Services | Outperform |
17
|
$23.21 | Buy/Sell | $26.67 | 24.95% |
BBSI Stock Forecast | Barrett Business Services | Outperform |
16
|
$125.98 | Buy/Sell | $130.75 | 11.53% |
HSII Stock Forecast | Heidrick & Struggles Internati... | Outperform |
17
|
$33.22 | Buy/Sell | $36.00 | 20.41% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HCKT Stock Forecast | The Hackett Group | Outperform |
18
|
$21.89 | Buy/Sell | $27.00 | 21.06% |
RGP Stock Forecast | Resources Connection | Hold |
18
|
$11.30 | Buy/Sell | $16.00 | 15.04% |
TBI Stock Forecast | TrueBlue | Outperform |
13
|
$10.82 | Buy/Sell | $17.67 | 20.15% |
Cross Country Healthcare EBITDA Forecast for 2023 - 2025 - 2030
Cross Country Healthcare's EBITDA has seen impressive growth In the last three years, rising from $25.89M to $134.96M – a growth of 421.28%. For the following year, the 7 analysts predict that Cross Country Healthcare's EBITDA will drop by 20.28%, reaching $107.59M. In 2030, the professionals' prediction is that CCRN's EBITDA will decrease by 15.67%, reaching $113.81M.
Cross Country Healthcare EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Cross Country Healthcare's EBIT has grown by 617.59%, rising from $16.32M to $117.11M. In the following year, the 4 analysts surveyed believe that Cross Country Healthcare's EBIT will decrease by 30.25%, reaching $81.68M. According to professionals, by 2030, Cross Country Healthcare's EBIT will have decreased by 21.53%, falling down to $91.90M.
Cross Country Healthcare EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Cross Country Healthcare's EPS has fallen from $0.46 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $1.57, which would mean an increase of 100.00%. Over the next seven years, experts predict that Cross Country Healthcare's EPS will grow at a rate of 100.00%.